OWENS DAVID (Chief Medical Officer) purchased 0.3% of their position (500.00 shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $1.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/30/2024ACC: 0001829126-24-007091
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+500.00
Net shares
Net buyer
$1.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
500.00 acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+500.00
Price / share
$2.19
Trade value
$1.09K
% of position
0.3%
10/28/2024
147.79K→148.29K
Total
Net shares
+500.00
Net value
$1.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 10/28/2024 | P · Purchase | +500.00 | $2.19 | $1.09K | 0.3% | 147.79K | 148.29K |
| Total | +500.00 | $1.09K | ||||||
Derivative Transactions0
No derivative transactions reported